参考文献/References:
[1] Rubin E J,Baden L R,Morrissey S,et al.Medical Journals and the 2019-nCoV Outbreak[J].N Engl J Med,2020,Jan 27.doi:10.1056/NEJMe2001329.[Epub ahead of print].
[2] Zhu N,Zhang D,Wang W,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019[J]. N Engl J Med,2020,Jan 24.doi:10.1056/NEJMoa2001017.[Epub ahead of print].
[3] Benvenuto D,Giovannetti M,Ciccozzi A,et al. The 2019-new coronavirus epidemic: evidence for virus evolution[J]. J Med Virol.2020 Jan 29.doi:10.1002/jmv.25688.[Epub ahead of print].
[4] Lee N,Hui D,Wu A,et al. A major outbreak of severe acute respiratory syndrome in Hong Kong[J]. N Engl J Med,2003,348(20):1986-1994.
[5] Lau S K,Woo P C,Li K S,et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats[J].Proc Natl Acad Sci USA,2005,102(39):14040-14045.
[6] Li W,Shi Z,Yu M,et al. Bats are natural reservoirs of SARS-like coronaviruses[J].Science,2005,310(5748):676-679.
[7] Shi Z, Hu Z. A review of studies on animal reservoirs of the SARS coronavirus[J].Virus Res,2008,133(1):74-87.
[8] Zaki A M, van Boheemen S, Bestebroer T M, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J]. N Engl J Med,2012,367(19):1814-1820.
[9] Ho W.Guideline on management of severe acute respiratory syndrome(SARS)[J].Lancet,2003,361(9366):1313-1315.
[10] Frieman M, Heise M, Baric R, et al.SARS coronavirus and innate immunity[J].Virus Res,2008,133(1):101-112.
[11] Deng X, Hackbart M, Mettelman R C,et al.Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages[J].Proc Natl Acad Sci USA,2017,114(21): E4251-E4260.
[12] Fehr A R, Channappanavar R,Jankevicius G,et al. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection[J].mBio 2016,7(6): e01721-16.
[13] Shokri S, Mahmoudvand S, Taherkhani R,et al.Modulation of the immune response by Middle East respiratory syndrome coronavirus[J].J Cell Physiol,2019,234(3):2143-2151.
[14] Prabakaran P,Xiao X, Dimitrov D S.A model of the ACE2 structure and function as a SARS-CoV receptor[J].Biochem Biophys Res Commun,2004,314(1):235-241.
[15] Zhu M.SARS Immunity and Vaccination[J].Cell Mol Immunol,2004,1(3):193-198.
[16] Wong R S, Wu A, To K F,et al.Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis[J].BMJ,2003,326(7403):1358-1362.
[17] Guan W D,Mok C K, Chen Z L,et al.Characteristics of traveler with Middle East Respiratory Syndrome, China, 2015[J].Emerg Infect Dis, 21(12):2278-2280.
[18] Ng O W, Chia A,Tan A T,et al.Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection[J].Vaccine,2016,34(17):2008-2014.
[19] Chu C M,Cheng V C,Hung I F,et al.Viral load distribution in SARS outbreak[J].Emerg Infect Dis,2005,11(12):1882-1886.
[20] Yu I T,Qiu H,Tse L A,et al.Severe acute respiratory syndrome beyond Amoy Gardens: completing the incomplete legacy[J].Clin Infect Dis,2014,58(5):683-686.
[21] Yu IT,Li Y,Wong T W,et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus[J].N Engl J Med,2004,350(17):1731-1739.
[22] Zaki A M,van Boheemen S,Bestebroer T M,et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J].N Engl J Med,2012,367(19):1814-1820.
[23] Hijawi B,Abdallat M,Sayaydeh A,et al. Novel Coronavirus Infections in Jordan, April 2012: Epidemiological Findings From a Retrospective Investigation[J].East Mediterr Health J,2013,19(Suppl 1):S12-S18.
[24] Booth T F,Kournikakis B,Bastien N,et al.Detection of airborne severe acute respiratory syndrome(SARS)coronavirus and environmental contamination in SARS outbreak units[J].J Infect Dis,2005,191(9):1472-1477.
[25] Yu I T,Wong T W,Chiu Y L,et al.Temporal–spatial analysis of severe acute respiratory syndrome among hospital inpatients[J].Clin Infect Dis,2005,40(9):1237-1243.
[26] The WHO MERS-CoV Research Group.State of knowledge and data gaps of Middle East respiratory syndrome coronavirus(MERS-CoV)in humans[J].PLoS Curr,2013,12:5.
[27] Assiri A,McGeer A,Perl T M,et al. Hospital outbreak of Middle East respiratory syndrome coronavirus[J].N Engl J Med,2013,369(5):407-416.
[28] Assiri A,Al-Tawfiq J A,Al-Rabeeah A A,et al.Epidemiological, demographic,and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study[J].Lancet Infect Dis,2013,13(9):752-761.
[29] Memish Z A,Zumla A I,Al-Hakeem R F,et al. Family cluster of Middle East respiratory syndrome coronavirus infections.[J].N Engl J Med,2013,368(26):2487-2494.
[30] Leung G M,Hedley A J,Ho L M,et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients[J].Ann Intern Med,2004, 141(9):662-673.
[31] 谢静,韩扬,李太生,等.重症急性呼吸综合征患者血浆细胞因子水平的动态改变[J].2003,42(9):643-645.
[32] Li Z,Guo X,Hao W,et al.The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome[J].Chin Med J(Engl),2003, 116(7):981-984.
[33] 段钟平,陈煜,张晶,等.严重急性呼吸道综合征并发肝脏损害的临床特点与机制探讨[J].中华肝脏病杂志, 2003,11(8):493-496.
[34] Wong C K,Lam C W,Wu A K,et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome[J].Clin Exp Immunol,2004,136(1):95-103.
[35] Jones B M,Ma E S,Peiris J S,et al.Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome(SARS)treated with ribavirin and steroids[J].Clin Exp Immunol,2004,135(3):467-473.
[36] Spiegel M,Schneider K,Weber F,et al. Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells[J].J Gen Virol,2006,87(Pt 7):1953-1960.
[37] Reghunathan R,Jayapal M,Hsu L Y,et al.Expression profile of immune response genes in patients with severe acute respiratory syndrome[J].BMC Immunol,2005(6):2.
[38] Zalinger Z B,Elliott R,Weiss S R.Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus[J].J Neurovirol,2017,23(6):845-854.
[39] Str?her U,DiCaro A,Li Y,et al.Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-α[J].J Infect Dis,2004,189(7):1164-1167.
[40] Cinatl J Jr,Michaelis M,Scholz M,et al.Role of interferons in the treatment of severe acute respiratory syndrome[J].Expert Opin Biol Ther,2004,4(6):827-836.
[41] Chang M S,Lu Y T,Ho S T,et al.Antibody detection of SARS-CoV spike and nucleocapsid protein[J].Biochem Biophys Res Commun,2004,314(4):931-936.
[42] Chen X,Zhou B,Li M,et al.Serology of severe acute respiratory syndrome:implications for surveillance and outcome[J].J Infect Dis,2004,189(7):1158-1163.
[43] Chen W,Xu Z,Mu J,et al.Antibody response and viraemia during the course of severe acute respiratory syndrome(SARS)-associated coronavirus infection[J].J Med Microbiol,2004,53(Pt 5):435-438.
[44] Wang J Q,Wen J,Li J X,et al.Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus[J].Clin Chem,2003,49(12):1989-1996.
[45] Li G,Chen X J,Xu A L.Profile of specific antibodies to the SARS-associated coronavirus[J].N Engl J Med,2003,349(5):508-509.
[46] Chan P K,Ng K C,Chan R C,et al.Immunofluorescence assay for serologic diagnosis of SARS[J].Emerg Infect Dis,2004,10(3):530-532.
[47] Woo P C,Lau S K,Wong B H,et al.Detection of specific antibodies to severe acute respiratory syndrome(SARS)coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia[J].J Clin Microbiol,2004,42(5):2306-2309.
[48] Isaacs A,Lindenmann J.Virus interference.I.The interferon[J].Proc R Soc Lond B Biol Sci,1957,147(927):258-267.
[49] Sen G C.Viruses and Interferons[J].Annu Rev Microbiol,2001,55:255-281.
[50] Cardenas W B,Loo Y M,Gale M Jr,et al.Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling[J].J Virol,2006,80(11):5168-5178.
[51] Hiscott J, Lacoste J, Lin R.Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: Disruption by hepatitis C virus NS3-4A protease[J].Biochem Pharmacol,2006,72(11):1477-1484.
[52] Hiscott J,Lin R,Nakhaei P,et al.Master CARD:a priceless link to innate immunity[J].Trends Mol Med,2006,12(2):53-56.
[53] Parisien J P,Lau J F,Rodriguez J J,et al.The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2[J].Virology,2001,283(2):230-239.
[54] Fung T S,Liu D X.Post-translational modifcations of coronavirus proteins: roles and function[J].Future Virol,2018,13(6):405-430.
[55] Ip W K,Chan K H,Law H K,et al.Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection[J].J Infect Dis,2005,191(10):1697-1704.
[56] Yuan F F,Tanner J,Chan P K,et al.Influence of FcRIIA and MBL polymorphisms on severe acute respiratory syndrome[J].Tissue Antigens,2005,66(4):291-296.
[57] Wang Y,Yan J,Shi Y,et al.Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection[J].BMC Infect Dis,2009,9:51.
[58] Jiang Y,Zhao G,Song N,et al.Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV[J].Emerg Microbes Infect,2018,7(1):77.
[59] Gralinski L E,Ferris M T,Aylor D L,et al.Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross[J].PLoS Genet,2015,11(10):e1005504.
[60] Fett C,DeDiego M L,Regla-Nava J A,et al.Complete protection against severe acute respiratory syndrome coronavirusmediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein[J].J Virol,2013,87(12):6551-6559.
[61] Franks T J,Chong P Y,Chui P,et al.Lung pathology of severe acute respiratory syndrome(SARS): a study of 8 autopsy cases from Singapore[J].Hum Pathol,2003,34(8):743-748.
[62] Naito A T,Sumida T,Nomura S,et al.Complement C1q activates canonical wnt signaling and promotes aging-related phenotypes[J].Cell,2012,149(6):1298-1313.
[63] Gralinski L E,Sheahan T P,Morrison T E,et al. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis[J].mBio,2018,9(5):e01753-18.
[64] Skinner D,Marro B S,Lane T E,et al.Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease[J].Viral Immunol,2019,32(1):25-37.
[65] Tynell J,Westenius V,R?nkk? E, et al.Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells[J].J.Gen.Virol,2016, 97(2):344-355.
[66] Cinatl J,Morgenstern B,Bauer G,et al.Treatment of SARS with human interferons[J].Lancet,2003,362(9380):293-294.
[67] Mair-Jenkins J, Saavedra-Campos M,Baillie J K,et al.The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis[J].J Infect Dis, 2015,211(1): 80-90.
[68] Corti D,Zhao J,Pedotti M,et al.Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus[J].Proc Natl Acad Sci USA,2015,112(33):10473-10478.
[69] de Wit E, van Doremalen N, Falzarano D,et al.SARS and MERS:recent insights into emerging coronaviruses[J].Nat Rev Microbiol,2016,14(8):523-534.
[70] Graham R L,Donaldson E F, Baric R S,et al.A decade after SARS:strategies for controlling emerging coronaviruses[J].Nat Rev Microbiol,2013,11(12):836-848.
[71] Guo X,Deng Y,Chen H,et al.Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus[J].Immunology,2015,145(4):476-484.
[72] Lan J,Yao Y,Deng Y,et al.Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge[J].E Bio Medicine,2015,2(10):1438-1446.
[73] Totura A L,Whitmore A,Agnihothram S,et al.Toll-Like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection[J].mBio,2015,6(3): e00638-15.
[74] Zhao J,Zhao J,Mangalam A K,et al.Airway Memory CD4(+)T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses[J].Immunity,2016,44(6):1379-1391.
[75] Razum O,Becher H,Kapaun A,et al.SARS,lay epidemiology,and fear[J].Lancet,2003,361(9370): 1739-1740.